Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 20, 2023

BUY
$7.32 - $10.85 $32,940 - $48,825
4,500 Added 300.0%
6,000 $60,000
Q3 2022

Oct 17, 2022

SELL
$10.73 - $20.07 $16,095 - $30,105
-1,500 Reduced 50.0%
1,500 $16,000
Q2 2022

Aug 02, 2022

BUY
$6.76 - $14.18 $13,317 - $27,934
1,970 Added 191.26%
3,000 $32,000
Q1 2022

May 09, 2022

BUY
$11.13 - $23.04 $5,565 - $11,520
500 Added 94.34%
1,030 $13,000
Q4 2021

Feb 14, 2022

BUY
$21.81 - $48.96 $6,543 - $14,688
300 Added 130.43%
530 $12,000
Q3 2021

Oct 29, 2021

BUY
$29.03 - $38.62 $870 - $1,158
30 Added 15.0%
230 $7,000
Q1 2021

May 11, 2021

BUY
$34.75 - $57.5 $6,950 - $11,500
200 New
200 $7,000

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.